In a report released yesterday, Joseph Thome from TD Cowen maintained a Buy rating on Prime Medicine, Inc. (PRME – Research Report). The ...

Encouraging Preclinical Data: Decoy20 has produced efficacy in preclinical studies across a variety of tumor types and in combination with four different classes of existing drugs, demonstrating both ...

Cathie Wood's ARK Innovation ETF (ARKK) has surged to its highest trading level in more than two years this week, surpassing ...

Canada ordered striking dock workers back to the ports of Vancouver, Prince Rupert and Montreal on Tuesday to clear out more ...

Since the 2023 financing round, Flare’s lead program FX-909 has moved into a phase 1 clinical trial for patients with ...

ALT5 Prime is an electronic over-the-counter trading platform ... The Company is working on the separation of our biotech business that will become known as 'Alyea Therapeutics.' Forward Looking ...

MRCLS had clinical responses with lete-celResults include six complete responses (6/64); twenty-one partial responses ...

But today, according to the Federal Trade Commission, the six largest PBMs — CVS Caremark, Express Scripts, OptumRx, Humana, Prime Therapeutics and MedImpact — manage nearly 95% of all prescriptions ...

Aptevo Therapeutics and Alligator Bioscience report favorable safety, tolerability and evidence of biological activity of ALG.APV-527, more than half of evaluable patients achieved stable diseaseColon ...

A new study in mice explains how even a single faulty copy of the BRCA1 gene can fuel tumor growth. The findings suggest the dominant “two-hit” hypothesis of cancer development may not tell the full ...

Johnson is co-founder of Boston-based Affinia Therapeutics and former CEO of UK biopharma Adrestia Therapeutics Kesmalea's SELFTAC® platform is designed to solve the 'size problem' of large, bifunctio ...

NeuroSense Therapeutics Ltd., a late-clinical stage biotechnology company developing novel treatments for severe neurodegenerative diseases – such as amyotrophic lateral sclerosis (ALS), Alzheimer’s ...